BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19276166)

  • 21. Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.
    Muñoz-Moreno L; Arenas MI; Schally AV; Fernández-Martínez AB; Zarka E; González-Santander M; Carmena MJ; Vacas E; Prieto JC; Bajo AM
    Int J Cancer; 2013 Feb; 132(4):755-65. PubMed ID: 22777643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcitonin induces apoptosis resistance in prostate cancer cell lines against cytotoxic drugs via the Akt/survivin pathway.
    Thomas S; Shah G
    Cancer Biol Ther; 2005 Nov; 4(11):1226-33. PubMed ID: 16222118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N'-Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as a potential anti-tumour agent for prostate cancer in experimental studies.
    Rodrigues JR; Charris J; Camacho J; Barazarte A; Gamboa N; Nitzsche B; Höpfner M; Lein M; Jung K; Abramjuk C
    J Pharm Pharmacol; 2013 Mar; 65(3):411-22. PubMed ID: 23356850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor.
    Thomas S; Chigurupati S; Anbalagan M; Shah G
    Mol Endocrinol; 2006 Aug; 20(8):1894-911. PubMed ID: 16574742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
    Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenylmethylene hydantoins as prostate cancer invasion and migration inhibitors. CoMFA approach and QSAR analysis.
    Khanfar MA; El Sayed KA
    Eur J Med Chem; 2010 Nov; 45(11):5397-405. PubMed ID: 20869139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.
    Tuomela JM; Valta MP; Väänänen K; Härkönen PL
    BMC Cancer; 2008 Mar; 8():81. PubMed ID: 18371232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone.
    Jennbacken K; Gustavsson H; Tesan T; Horn M; Vallbo C; Welén K; Damber JE
    Prostate; 2009 Aug; 69(11):1164-75. PubMed ID: 19399749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis.
    Huang S; Pettaway CA; Uehara H; Bucana CD; Fidler IJ
    Oncogene; 2001 Jul; 20(31):4188-97. PubMed ID: 11464285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GLB prevents tumor metastasis of Lewis lung carcinoma by inhibiting tumor adhesion actions.
    Pan Y; Song QL; Lin YH; Lu N; Yu HM; Li XJ
    Acta Pharmacol Sin; 2005 Jul; 26(7):881-6. PubMed ID: 15960897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
    Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.
    Liu X; Peng J; Sun W; Yang S; Deng G; Li F; Cheng JW; Gordon JR
    Tohoku J Exp Med; 2012 Oct; 228(2):147-56. PubMed ID: 23019013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell adhesion molecule CD44: its functional roles in prostate cancer.
    Iczkowski KA
    Am J Transl Res; 2010 Sep; 3(1):1-7. PubMed ID: 21139802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.
    Thomas S; Chiriva-Internati M; Shah GV
    Clin Exp Metastasis; 2007; 24(5):363-77. PubMed ID: 17487556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin.
    Olson KA; Byers HR; Key ME; Fett JW
    Clin Cancer Res; 2001 Nov; 7(11):3598-605. PubMed ID: 11705882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model.
    Rahim S; Minas T; Hong SH; Justvig S; Çelik H; Kont YS; Han J; Kallarakal AT; Kong Y; Rudek MA; Brown ML; Kallakury B; Toretsky JA; Üren A
    PLoS One; 2014; 9(12):e114260. PubMed ID: 25479232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Rajamanickam S; Singh RP; Deep G; Chittezhath M; Agarwal R
    Cancer Res; 2008 Aug; 68(16):6822-30. PubMed ID: 18701508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.